CTLA4 CT60 single-nucleotide polymorphism is associated with slovenian inflammatory bowel disease patients and regulates expression of CTLA4 isoforms

DNA and Cell Biology

Volumn 29, Issue 10, 2010, Pages 603-610

  Repnik, Katja ^a   Potočnik, Uroš ^a  

^a UNIVERSITY OF MARIBOR   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ISOPROTEIN; CTLA4 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ADULT; ALLELE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SLOVENIA; ULCERATIVE COLITIS; BLOOD; CASE CONTROL STUDY; COLON; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; MIDDLE AGED;

ADULT; ANTIGENS, CD; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; CTLA-4 ANTIGEN; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; SLOVENIA;

EID: 77957744658     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2010.1021     Document Type: Article

References (45)

1. Atabani, S. F., Thio, C. L., Divanovic, S., Trompette, A., Belkaid, Y., Thomas, D. L., and Karp, C. L. (2005). Association of CTLA4 polymorphism with regulatory T cell frequency. Eur J Immunol 35, 2157-2162.
2. Bairead, E., Harmon, D. L., Curtis, A. M., Kelly, Y., O'Leary, C., Gardner, M., Leahy, D. T., Vaughan, P., Keegan, D., O'Morain, C., O'Donoghue, D., Shanahan, F., Parfrey, N. A., and Quane, K. A. (2003). Association of NOD2 with Crohn's disease in a homogenous Irish population. Eur J Hum Genet 11, 237-244.
3. Barrett, J. C., Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., Silverberg, M. S., Taylor, K. D., Barmada, M. M., Bitton, A., Dassopoulos, T., Datta, L. W., Green, T., Griffiths, A. M., Kistner, E. O., Murtha, M. T., Regueiro, M. D., Rotter, J. I., Schumm, L. P., Steinhart, A. H., Targan, S. R., Xavier, R. J., Libioulle, C., Sandor, C., Lathrop, M., Belaiche, J., Dewit, O., Gut, I., Heath, S., Laukens, D., Mni, M., Rutgeerts, P., Van, G. A., Zelenika, D., Franchimont, D., Hugot, J. P., de, V. M., Vermeire, S., Louis, E., Cardon, L. R., Anderson, C. A., Drummond, H., Nimmo, E., Ahmad, T., Prescott, N. J., Onnie, C. M., Fisher, S. A., Marchini, J., Ghori, J., Bumpstead, S., Gwilliam, R., Tremelling, M., Deloukas, P., Mansfield, J., Jewell, D., Satsangi, J., Mathew, C. G., Parkes, M., Georges, M., and Daly, M. J. (2008). Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40, 955-962.
4. Blomhoff, A., Lie, B. A., Myhre, A. G., Kemp, E. H., Weetman, A. P., Akselsen, H. E., Huseby, E. S., and Undlien, D. E. (2004). Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J Clin Endocrinol Metab 89, 3474-3476.
5. Cho, J. H. (2008). The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 8, 458-466.
6. Coombes, J. L., and Powrie, F. (2008). Dendritic cells in intestinal immune regulation. Nat Rev Immunol 8, 435-446.
7. Economou, M., Trikalinos, T. A., Loizou, K. T., Tsianos, E. V., and Ioannidis, J. P. (2004). Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 99, 2393-2404.
8. Franke, A., Balschun, T., Karlsen, T. H., Sventoraityte, J., Nikolaus, S., Mayr, G., Domingues, F. S., Albrecht, M., Nothnagel, M., Ellinghaus, D., Sina, C., Onnie, C. M., Weersma, R. K., Stokkers, P. C., Wijmenga, C., Gazouli, M., Strachan, D., McArdle, W. L., Vermeire, S., Rutgeerts, P., Rosenstiel, P., Krawczak, M., Vatn, M. H., Mathew, C. G., and Schreiber, S. (2008). Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 40, 1319-1323.
9. Gu, M., Kakoulidou, M., Giscombe, R., Pirskanen, R., Lefvert, A. K., Klareskog, L., and Wang, X. (2008). Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis. Clin Immunol 128, 374-381.
10. Hou, W., Xia, B., Yuan, A., Li, J., Yang, Z., and Mao, L. (2005). CTLA-4 gene polymorphisms in Chinese patients with ulcerative colitis. Inflamm Bowel Dis 11, 653-656.
11. Howson, J. M., Dunger, D. B., Nutland, S., Stevens, H., Wicker, L. S., and Todd, J. A. (2007). A type 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic T-lymphocyte-associated antigen-4 gene. Diabetologia 50, 741-746.
12. Hugot, J. P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J. P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., Binder, V., Finkel, Y., Cortot, A., Modigliani, R., Laurent-Puig, P., Gower-Rousseau, C., Macry, J., Colombel, J. F., Sahbatou, M., and Thomas, G. (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603.
13. Jiang, Y., Xia, B., Jiang, L., Lv, M., Guo, Q., Chen, M., Li, J., Xia, H. H., and Wong, B. C. (2006). Association of CTLA-4 gene microsatellite polymorphism with ulcerative colitis in Chinese patients. Inflamm Bowel Dis 12, 369-373.
14. Kristiansen, O. P., Larsen, Z. M., and Pociot, F. (2000). CTLA-4 in autoimmune diseases-a general susceptibility gene to autoimmunity? Genes Immun 1, 170-184.
15. Kuiper, H. M., Brouwer, M., Linsley, P. S., and van Lier, R. A. (1995). Activated T cells can induce high levels of CTLA-4 expression on B cells. J Immunol 155, 1776-1783.
16. Lankarani, K. B., Karbasi, A., Kalantari, T., Yarmohammadi, H., Saberi-Firoozi, M., Izadeh-Naeeni, M., Taghavi, A. R., Fattahi, M. R., and Ghaderi, A. (2006). Analysis of cytotoxic T lymphocyte associated antigen 4 gene polymorphisms in patients with ulcerative colitis. J Gastroenterol Hepatol 21, 449-453.
17. Lindsten, T., Lee, K. P., Harris, E. S., Petryniak, B., Craighead, N., Reynolds, P. J., Lombard, D. B., Freeman, G. J., Nadler, L. M., and Gray, G. S. (1993). Characterization of CTLA-4 structure and expression on human T cells. J Immunol 151, 3489-3499.
18. Linsley, P. S., Greene, J. L., Brady, W., Bajorath, J., Ledbetter, J. A., and Peach, R. (1994). Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1, 793-801.
19. Linsley, P. S., Nadler, S. G., Bajorath, J., Peach, R., Leung, H. T., Rogers, J., Bradshaw, J., Stebbins, M., Leytze, G., and Brady, W. (1995). Binding stoichiometry of the cytotoxic T lymphocyteassociated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 molecules. J Biol Chem 270, 15417-15424.
20. Liu, Z., Geboes, K., Hellings, P., Maerten, P., Heremans, H., Vandenberghe, P., Boon, L., van, K. P., Rutgeerts, P., and Ceuppens, J. L. (2001). B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis. J Immunol 167, 1830-1838. (Pubitemid 32703188)
21. Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) method. Methods 25, 402-408.
22. Luo, Y., Xia, B., Li, C, Chen, Z., Ge, L., Jiang, T., Zhou, F., and Zhao, Y. (2009). Cytotoxic T lymphocyte antigen-4 promoter - 658CT gene polymorphism is associated with ulcerative colitis in Chinese patients. Int J Colorectal Dis 24, 489-493.
23. Machida, H., Tsukamoto, K., Wen, C. Y., Narumi, Y., Shikuwa, S., Isomoto, H., Takeshima, F., Mizuta, Y., Niikawa, N., Murata, I., and Kohno, S. (2005). Association of polymorphic alleles of CTLA4 with inflammatory bowel disease in the Japanese. World J Gastroenterol 11, 4188-4193.
24. Magyari, L., Farago, B., Bene, J., Horvatovich, K., Lakner, L., Varga, M., Figler, M., Gasztonyi, B., Mozsik, G., and Melegh, B. (2007). No association of the cytotoxic T-lymphocyte associated gene CTLA4 + 49A/G polymorphisms with Crohn's disease and ulcerative colitis in Hungarian population samples. World J Gastroenterol 13, 2205-2208.
25. Mathew, C. G. (2008). New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nat Rev Genet 9, 9-14.
26. Mayans, S., Lackovic, K., Nyholm, C, Lindgren, P., Ruikka, K., Eliasson, M., Cilio, CM., and Holmberg, D. (2007). CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden. BMC Med Genet 8, 3.
27. McCoy, K. D., Hermans, I. F., Fraser, J. H., Le, G. G., and Ronchese, F. (1999). Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can regulate dendritic cell-induced activation and cytotoxicity of CD8 (+) T cells independently of CD4 (+) T cell help. J Exp Med 189, 1157-1162.
28. Niess, J. H. (2008). Role of mucosal dendritic cells in inflammatory bowel disease. World J Gastroenterol 14, 5138-5148.
29. Oaks, M. K., Hallett, K. M., Penwell, R. T., Stauber, E. C., Warren, S. J., and Tector, A. J. (2000). A native soluble form of CTLA-4. Cell Immunol 201, 144-153.
30. Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., Achkar, J. P., Brant, S. R., Bayless, T. M., Kirschner, B. S., Hanauer, S. B., Nunez, G., and Cho, J. H. (2001). A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606.
31. Palacios, R., Comas, D., Elorza, J., and Villoslada, P. (2008). Genomic regulation of CTLA4 and multiple sclerosis. J Neuroimmunol 203, 108-115.
32. Perez-Garcia, A., Brunet, S., Berlanga, J. J., Tormo, M., Nomdedeu, J., Guardia, R., Ribera, J. M., Heras, I., Llorente, A., Hoyos, M., Esteve, J., Besalduch, J., Bueno, J., Sierra, J., and Gallardo, D. (2009). CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy. Leukemia 23, 486-491.
33. Petrone, A, Giorgi, G., Galgani, A, Alemanno, I., Corsello, S. M., Signore, A, Di, M. U., Nistico, L., Cascino, I., and Buzzetti, R. (2005). CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. Thyroid 15, 232-238.
34. Potocnik, U., Ferkolj, I., Glavac, D., and Dean, M. (2004). Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis. Genes Immun 5, 530-539.
35. Silverberg, M. S., Cho, J. H., Rioux, J. D., McGovern, D. P., Wu, J., Annese, V., Achkar, J. P., Goyette, P., Scott, R., Xu, W., Barmada, M. M., Klei, L., Daly, M. J., Abraham, C., Bayless, T. M., Bossa, F., Griffiths, A. M., Ippoliti, A. F., Lahaie, R. G., Latiano, A., Pare, P., Proctor, D. D., Regueiro, M. D., Steinhart, A. H., Targan, S. R., Schumm, L. P., Kistner, E. O., Lee, A. T., Gregersen, P. K., Rotter, J. I., Brant, S. R., Taylor, K. D., Roeder, K., and Duerr, R. H. (2009). Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 41, 216-220.
36. Teft, W. A., Kirchhof, M. G., and Madrenas, J. (2006). A molecular perspective of CTLA-4 function. Annu Rev Immunol 24, 65-97.
37. The Wellcome Trust Case Control Consortium. (2007). Genomewide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 447, 661-678.
38. Torres, B., Aguilar, F., Franco, E., Sanchez, E., Sanchez-Roman, J., Jimenez, A. J., Nunez-Roldan, A., Martin, J., and Gonzalez-Escribano, M. F. (2004). Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus. Arthritis Rheum 50, 2211-2215.
39. Ueda, H., Howson, J. M., Esposito, L., Heward, J., Snook, H., Chamberlain, G., Rainbow, D. B., Hunter, K. M., Smith, A. N., Di, G. G., Herr, M. H., Dahlman, I., Payne, F., Smyth, D., Lowe, C., Twells, R. C., Howlett, S., Healy, B., Nutland, S., Rance, H. E., Everett, V., Smink, L. J., Lam, A. C., Cordell, H. J., Walker, N. M., Bordin, C., Hulme, J., Motzo, C., Cucca, F., Hess, J. F., Metzker, M. L., Rogers, J., Gregory, S., Allahabadia, A., Nithiyananthan, R., Tuomilehto-Wolf, E., Tuomilehto, J., Bingley, P., Gillespie, K. M., Undlien, D. E., Ronningen, K. S., Guja, C., Ionescu-Tirgoviste, C., Savage, D. A., Maxwell, A. P., Carson, D. J., Patterson, C. C., Franklyn, J. A., Clayton, D. G., Peterson, L. B., Wicker, L. S., Todd, J. A., and Gough, S. C. (2003). Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506-511. (Pubitemid 36648570)
40. van Belzen, M. J., Mulder, C. J., Zhernakova, A., Pearson, P. L., Houwen, R. H., and Wijmenga, C. (2004). CTLA4+49A/G and CT60 polymorphisms in Dutch coeliac disease patients. Eur J Hum Genet 12, 782-785.
41. van Heel, D. A., Fisher, S. A., Kirby, A., Daly, M. J., Rioux, J. D., and Lewis, C. M. (2004). Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet 13, 763-770.
42. Walker, E. J., Hirschfield, G. M., Xu, C., Lu, Y., Liu, X., Lu, Y., Coltescu, C., Wang, K., Newman, W. G., Bykerk, V., Keystone, E. C., Mosher, D., Amos, C. I., Heathcote, E. J., and Siminovitch, K. A. (2009). CTLA4/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population. Arthritis Rheum 60, 931-937.
43. Xavier, R. J., and Podolsky, D. K. (2007). Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434.
44. Xia, B., Crusius, J. B., Wu, J., Zwiers, A., van Bodegraven, A. A., and Pena, A. S. (2002). CTLA4 gene polymorphisms in Dutch and Chinese patients with inflammatory bowel disease. Scand J Gastroenterol 37, 1296-1300.
45. Zhang, H., Massey, D., Tremelling, M., and Parkes, M. (2008). Genetics of inflammatory bowel disease: clues to pathogenesis. Br Med Bull 87, 17-30.